NIH-funded research R01 grant

Engineering cartilage to improve healing in osteoarthritis

Official title: Molecular Engineering of Cartilage PCM Mechanotransduction in Osteoarthritis Using Biomimetic Proteoglycans

Funded at Villanova University · NIH-10869996 · Data updated 2026-11-12

This study is working on creating new materials that mimic natural cartilage to help improve healing in people with osteoarthritis, aiming to make treatments better so you can feel less pain and move more easily.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVillanova University
NIH-funded
Lab location1 site (Villanova, United States)
Project startJuly 10, 2022
Project endJune 30, 2027
Funding year2024
Award (this year)$303,714
NIH project number5R01AR080139-03
Project IDNIH-10869996 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with osteoarthritis, particularly those experiencing significant cartilage degeneration.

Less likely to help

Patients with osteoarthritis who have already undergone extensive joint surgeries or have advanced joint damage may not benefit from this research.

What this research studies

This research focuses on developing new biomimetic proteoglycans to enhance the healing of cartilage affected by osteoarthritis. By engineering the pericellular matrix surrounding cartilage cells, the study aims to improve how these cells respond to mechanical signals, which is crucial for cartilage regeneration. The approach involves creating a synthetic version of the natural cartilage matrix to support cell function and promote healing. Patients may benefit from advancements in treatments that could alleviate pain and restore function in osteoarthritis.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that significantly improve cartilage healing and reduce pain for osteoarthritis patients.

How similar studies have gone: While the approach of engineering the pericellular matrix is innovative, similar strategies in cartilage regeneration have shown promise in preliminary studies.

Where this research is happening

  • Villanova University
    Villanova, United States
    Active

Researchers

  • Principal investigator: Marcolongo, Michele S — Villanova University
  • Study coordinator: Marcolongo, Michele S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.